Moleculin Biotech Inc (NASDAQ:MBRX) has a beta value of 1.31 and has seen 2.84 million shares traded in the last trading session. The company, currently valued at $13.26M, closed the last trade at $0.55 per share which meant it gained $0.02 on the day or 3.01% during that session. The MBRX stock price is -756.36% off its 52-week high price of $4.71 and 54.55% above the 52-week low of $0.25. If we look at the company’s 10-day average daily trading volume, we find that it stood at 15.07 million shares traded. The 3-month trading volume is 4.26 million shares.
Moleculin Biotech Inc (NASDAQ:MBRX) trade information
Sporting 3.01% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the MBRX stock price touched $0.55 or saw a rise of 21.43%. Year-to-date, Moleculin Biotech Inc shares have moved -83.08%, while the 5-day performance has seen it change 61.79%. Over the past 30 days, the shares of Moleculin Biotech Inc (NASDAQ:MBRX) have changed -16.90%. Short interest in the company has seen 1.93 million shares shorted with days to cover at 2.21.
Moleculin Biotech Inc (MBRX) estimates and forecasts
The company’s shares have lost -69.27% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 26.36% over the past 5 years. Earnings growth for 2025 is a modest 75.21% while over the next 5 years, the company’s earnings are expected to increase by 42.60%.
MBRX Dividends
Moleculin Biotech Inc is expected to release its next earnings report on 2025-May-13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Moleculin Biotech Inc (NASDAQ:MBRX)’s Major holders
Insiders own 4.42% of the company shares, while shares held by institutions stand at 6.13% with a share float percentage of 6.42%. Investors are also buoyed by the number of investors in a company, with Moleculin Biotech Inc having a total of 24.0 institutions that hold shares in the company. The top two institutional holders are ARMISTICE CAPITAL, LLC with over 0.16 million shares worth more than $0.55 million. As of 2024-06-30, ARMISTICE CAPITAL, LLC held 6.1339% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 84418.0 shares as of 2024-06-30. The firm’s total holdings are worth over $0.3 million and represent 3.3193% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 0.21% shares in the company for having 30.31 shares of worth $16675.0 while later fund manager owns 18.49 shares of worth $10171.0 as of May 31, 2025 , which makes it owner of about 0.13% of company’s outstanding stock.
